Bidirectional contact tracing dramatically improves COVID-19 control

Contact tracing is critical to controlling COVID-19, but most protocols only “forward-trace” to notify people who were recently exposed. Using a stochastic branching-process model, we show that “bidirectional” tracing to identify infector individuals and their other infectees robustly improves outbreak control, reducing the effective reproduction number (​R ​ eff​) by at least ~0.3 while dramatically increasing resilience to low case ascertainment and test sensitivity. Adding smartphone-based exposure notification can further reduce ​R​eff by 0.25, but only if nearly all smartphones can detect exposure events. ​Our results suggest that with or without digital approaches, implementing bidirectional tracing will enable health agencies to control COVID-19 more effectively without requiring high-cost interventions.


Introduction
Contact tracing, isolation, and testing are some of the most powerful public health interventions available. The nations that have most effectively controlled the ongoing COVID-19 pandemic are noteworthy for conducting comprehensive and sophisticated tracing and testing 1 . Current "forward-tracing" protocols seek to identify and isolate individuals who may have been infected by the known case, preventing continued transmission (Fig. 1a). For example, the European Union and World Health Organization call for the identification of contacts starting two days prior to the development of symptoms 2,3 .
However, chains of SARS-CoV-2 transmission may persist despite excellent medical monitoring and forward-tracing programs due to substantial rates of undiagnosed or asymptomatic transmission 4 (Fig. 1a). Asymptomatic carriers, who reportedly bear equivalent viral loads to patients exhibiting symptoms 5 , have been estimated to account for 18% 6 to 79% 7 of cases, with multiple population surveys indicating intermediate values around 45% 8-10 .
We hypothesized that when asymptomatic carriers are common, "bidirectional" contact tracing could identify and isolate undiscovered branches of the transmission tree, preventing many additional cases (Fig. 1b). Bidirectional contact tracing uses "reverse-tracing" to identify the parent case who infected a known case, then continues tracing to iteratively discover other cases related to the parent. It has been successfully used to identify clusters and community transmission in Japan 12 and Singapore 13,14 , but is

Bidirectional tracing improves epidemic control in manual and idealized digital scenarios
In our model, each case generates a number of new cases drawn from a negative binomial distribution, with incubation and generation-time distributions based on the published literature (Table 1 & Table S1). Cases could be identified and isolated based on symptoms alone or through contact tracing (Methods). Each outbreak was initialized with 20 index cases to minimize stochastic extinction, and designated as "controlled" if it reached extinction (zero new cases) before reaching 10,000 cumulative cases.
We began by investigating a median scenario in which 10% of transmission was assumed to be environmental (and therefore untraceable), 48% of transmission occurred pre-symptomatically, and 45% of cases were asymptomatic with reduced (50%) infectiousness. For the initial analysis we assumed a fixed basic reproduction number ( R 0 ) of 2.5 (Fig. 2), but explored other R 0 values below. In this scenario, manual forward tracing of contacts occurring up to 48 hours before symptom onset per current guidelines 2 reduced R eff as anticipated, but not nearly enough to control the pandemic without other measures: even if all non-environmental contacts within that time window were successfully traced, R eff remained in excess of 1.4 (Fig. 2a). Extending the tracing window to 7 days before symptom onset yielded a moderate improvement, reducing the best-case R eff by roughly 0.2 ( Fig. 2a and Fig. S1); further widening of the tracing window resulted in minimal additional benefit (Fig. S2). Switching from forward-only to bidirectional tracing offered a further gain of similar magnitude, bringing the best-case R eff close to the critical threshold of 1.0. Even here, however, the fraction of outbreaks controlled was less than 50% (Fig. 2e).
Compared to manual tracing, digital exposure notification is both faster and scalable to much wider time windows. When all contacts in the past 14 days were available for analysis 11 , idealized digital forward-tracing produced markedly superior outcomes relative to manual forward-tracing (Fig. 2b), in agreement with earlier models 4 . Crucially, bidirectional digital tracing exhibited an even more dramatic improvement over the forward-only approach, successfully bringing R eff below 1.0 without any other control measures (Fig. 2b) and more than doubling the best-case probability of control (Fig. S5).

Digital tracing is fragile to network fragmentation
Idealized digital contact tracing appears promising, but assumes all individuals carry exposure-detecting smartphones and upload their broadcasted chirps when diagnosed with COVID-19. We hypothesized that the effectiveness of digital tracing would rapidly degrade when fewer people participated, in line with or worse than the quadratic dependence noted by others 4,16,18 .
As predicted, even small decreases in the proportion of individuals carrying a participating smartphone or (to a lesser extent) sharing their broadcasted chirps resulted in fragmentation of the tracing network ( , increasing R eff to levels comparable to, or even worse than, manual tracing alone. As a consequence of this fragility, our results suggest that digital tracing alone cannot currently substitute for traditional manual tracing, even under very optimistic assumptions about uptake and use 19,20 .

Hybridizing manual and digital tracing improves performance
Neither manual nor digital contact tracing alone sufficed to control COVID-19 in our median scenario. Digital tracing is fast and comprehensive but highly fragile to network fragmentation; manual tracing is slower and limited to a narrow time window, but more robust. We hypothesized that the two methods could complement each other, with manual contact tracers focusing their effort on tracing contacts invisible to the digital system, and that this hybrid approach might outperform either method in isolation.
When 80% of cases participated in the digital system, supplementing bidirectional manual with digital tracing substantially improved epidemic control (Fig. 2d), reducing best-case R eff by roughly 0.15 compared to manual tracing and more than 0.5 compared to digital tracing with equivalent uptake. Compared to manual tracing, a hybrid approach roughly doubled the probability of controlling individual outbreaks (Fig. 2e). Control under hybrid tracing was still somewhat sensitive to uptake of the digital system (Fig. 2f); but far less so than digital tracing alone. Performing only forward-tracing, or reducing the width of the manual tracing window, substantially degraded performance (Fig. 2d- 5 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 14, 2020.

Bidirectional tracing is robust to low case ascertainment and test sensitivity
Our results thus far assume that 90% of symptomatic cases can be identified based on symptoms alone, corresponding to an overall ascertainment rate (including asymptomatic cases) of roughly 50%. Unsurprisingly, reducing the percentage of symptomatic cases so identified impaired epidemic control ( Fig. 3a & Fig. S31). However, bidirectional tracing was far more robust to these changes than forward-only tracing, resulting in dramatically lower R eff values across a wide range of ascertainment rates.
When symptomatic cases can be traced immediately based on symptoms alone (our default assumption), , both forward-only and bidirectional tracing were fairly robust to deviations in test sensitivity from our default assumption of 80%, with R eff values increasing only slowly as sensitivity falls (Fig. 3b). In contrast, if a positive test result was required before tracing from symptomatic cases (as is the case in many countries 21 ), the efficacy of forward-tracing became dramatically more dependent on a high test sensitivity: low sensitivities yielded greatly increased R eff values ( Fig. 3c & Fig. S30), consistent with previous modeling studies reporting impaired performance under these conditions 21 . In sharp contrast, the performance of bidirectional tracing remained relatively robust to changes in test sensitivity even under these conditions. forward-only or bidirectional) as a function of (a) the percentage of symptomatic cases that can be identified by health authorities based on symptoms or (b-c) test sensitivity, assuming 90% probability of trace success, a 7-day manual tracing window, high-uptake digital tracing, and median disease parameters (Table S1). In (a-b), tracing can be initiated from symptomatic cases without a test, while in (c) a positive test result is required; in both cases, a positive test result is required to initiate tracing from pre-or asymptomatic cases. (a) assumes test sensitivity of 80%, while (b-c) assume 90% of symptomatic cases are identified on the basis of symptoms. "Probability of trace success" refers to trace attempts that are not otherwise blocked by environmental transmission or fragmentation of the digital network.

High-uptake hybrid bidirectional tracing robustly doubles the probability of outbreak control
To evaluate the epidemiological robustness of our findings, we repeated our analysis using R 0 values ranging from 1.0 to 4.0 (Fig. 4, left) 4,9,22-24 . We assumed tracing of 90% of non-environmental contacts, a 7-day manual trace window, immediate tracing of symptomatic cases, and high uptake of the digital system. A wider range of assumptions are explored in Figures S9-S31.
Small reductions in R 0 resulted in large increases in control probability across all forms of tracing (Fig. 4, left). Hybrid bidirectional tracing robustly outperformed all other tracing strategies, with the greatest degree of outperformance observed when 1.75 ≤ R 0 ≤ 3.5. When R 0 ≤ 1.75, manual and hybrid tracing both achieved nearly 100% control, while when R 0 ≥ 3.5, no strategy achieved control probabilities over 10%. Even in these low-control scenarios, however, hybrid bidirectional tracing consistently reduced R eff by roughly 20% relative to manual tracing alone ( Fig. 4 & Figs. S19-S20, S22, S32). Constraining manual tracing to a 2-rather than 7-day window substantially impaired performance (Fig. S10), while lowering uptake of the digital system from 80% to 53% of cases -in line with existing survey data 19-21 and current plans for opt-in participation 11 -mostly abrogated the advantage of hybrid over manual approaches (Figs. S16 and S21-S22).  (Table S1), 90% non-environmental contacts traced, a 7-day manual trace window, and high-uptake digital tracing. Error bars in the top row represent 95% credible intervals across 1000 runs under a uniform beta prior; points in the bottom row represent average values over the same. Isolating symptomatic cases can dampen the outbreak at low R 0 , even in the absence of tracing.
While COVID-19 is clearly a challenging disease to control, there remains substantial uncertainty around the exact rates of asymptomatic, presymptomatic, and environmental transmission. To explore a wider range of scenarios, we aggregated our collective best estimates to define optimistic and pessimistic values for these parameters, with 5/15% environmental transmission, 38/53% pre-symptomatic transmission, and 40/55% asymptomatic carriers which were 45/60% as infectious as symptomatic cases. We repeated our simulations under these new assumptions for a range of R 0 values (Fig. 4, middle & right).
While hybrid bidirectional tracing continued to robustly outperform other configurations (Figs. S17-S22), the probability of control varied substantially between scenarios: in the optimistic scenario, high-uptake hybrid bidirectional tracing was sufficient to reliably control outbreaks whenever R 0 ≤ 2.5, while in the pessimistic scenario reliable control was only achieved at R 0 ≤ 1.75. Restricting uptake of the digital system or the width of the manual tracing window impaired performance across all scenarios (Figs. S10 & S16-S22).
To summarize the predicted effects of different approaches, we compared the percentage of outbreaks controlled and R eff values achieved under all three scenarios, in the absence of any other interventions (Fig. 5, & Figs. S33-S36). Relative to optimal current practice (i.e. 2-day forward-only manual tracing), 7-day bidirectional manual tracing achieved a reduction in R eff of roughly 0.3 across all scenarios. Supplementing manual tracing with a low-uptake digital system provided a further reduction of 0.1 in the median and pessimistic scenarios, increasing to 0.25 (i.e., 0.55 total) when uptake was high. In total, switching from current practice to high-uptake hybrid bidirectional tracing approximately tripled the probability of controlling the spread of SARS-CoV-2 across all three scenarios.

Discussion
Given the tremendous suffering inflicted by the COVID-19 pandemic and the potentially critical role of expanding contact-tracing systems in its control, there is an urgent need to optimize the implementation of these systems.
Our model predicts that making tracing bidirectional would markedly improve COVID-19 control. Indeed, for a contact-tracing system to reach the levels of control cited by earlier studies 4,21 , we find that bidirectional tracing is required . Bidirectional tracing outperforms forward-tracing regardless of how the tracing is done. Simply switching to manual bidirectional tracing is sufficient to reduce R eff by 0.3 if the time window for tracing is sufficiently wide, while high-uptake bidirectional hybrid tracing is predicted to be approximately three times as effective at controlling outbreaks as current best practice. The case for bidirectional tracing becomes even stronger when case ascertainment is otherwise suboptimal, or if a positive test result is required before tracing the contacts of a symptomatic case.
8 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.  (Table S1), assuming an R 0 of 2.5, 90% of non-environmental contacts traced, 2-or 7-day manual trace windows, and immediate (pre-test) tracing of symptomatic cases. Blue ‡ symbols indicate current practice in most regions. Low and high uptake correspond to 53% and 80% of cases, respectively, having chirp-enabled smartphones. Error bars in the top row represent 95% credible intervals across 1000 runs under a uniform beta prior. Without tracing, forward and bidirectional are equivalent.
We stress-tested these conclusions with a wide range of plausible parameter combinations and possible values of R 0 . Notably, our "optimistic" scenario is more pessimistic than some earlier studies due to recent studies reporting higher values for both the rate and relative infectiousness of asymptomatic carriers 5,9,23,25,26 . Whether hybrid bidirectional tracing alone was sufficient to reliably control the pandemic was dependent on epidemiological parameters; however, if other low-cost precautions 27 could reduce R eff below 1.75, our model predicts that this strategy would bring transmission under control with high probability even under our pessimistic scenario.
Despite this stress-testing, our conclusions must be considered in the context of our model, which, while less idealized than its predecessors, has limitations. It makes no distinction between mild and severe symptoms, and does not consider demographic, geospatial or behavioural variation between cases. Since only true cases are included in the model, only the sensitivity of testing is considered; in reality, the 9 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.
balance between test sensitivity and specificity is a crucial trade-off, and high rates of false positives will severely impede response effectiveness and the credibility of the tracing system. These limitations aside, there is considerable evidence that bidirectional tracing can be feasibly implemented in practice. Locales such as Singapore 13,14 and Washington State 28 have employed bidirectional tracing to determine whether community transmission is occurring, while Japan's protocol explicitly aims to identify sources of infection 12 . The primary practical difference between contact with an infector and an infectee is the time at which the contact occurred; as such, the core obstacle to implementation in other areas is the cost of expanding the tracing window. Health authorities could accomplish this by expanding the workforce of contact tracers, leveraging the lightened workload afforded by a high-uptake digital system, or focusing limited resources on clusters as is done in Japan. Digital systems, which already track exposures for 14 days, can trace bidirectionally at no additional cost.
In addition to effective implementation of bidirectional tracing, a successful control program will also depend on the availability of timely COVID-19 testing 15 , high adherence to quarantine requests 4,17,29,30 , and scaling of manual contact tracing, while digital systems will require efficient algorithms with acceptable sensitivity and specificity. These caveats notwithstanding, our results indicate that bidirectional contact tracing could play an essential and potentially decisive role in controlling COVID-19 and preventing future pandemics.

Acknowledgments
We thank Aaron Bucher of the COVID-19 HPC Consortium and Amazon Web Services for granting us extra cloud compute credits. Data and Code Availability: Code for configuring and running the model is publicly available at https://github.com/willbradshaw/covid-bidirectional-tracing.

10
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020. 13 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020. 15 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Structure of the model -Infection dynamics
A new case is infected at some exposure time , equal to zero if the case is an index case and otherwise drawn from the generation time distribution of its parent case (see below). If not asymptomatic, the case develops symptoms at some onset time drawn from an incubation time distribution . Asymptomatic cases do not develop symptoms, but are still assigned an onset time for the purpose of determining their generation-time distribution (see below).
The number of child cases infected by the case is drawn from a negative binomial distribution, with mean equal to the appropriate reproduction number (see below) and heterogeneity determined by the overdispersion parameter k . The exposure times of these child cases are drawn from a skewed-normal generation time distribution centered on the symptom onset of their parent 17 , with a skew parameter chosen to give a pre-specified probability of pre-symptomatic transmission (for a symptomatic parent) and an SD parameter of 2. The generation time distribution for an asymptomatic parent is centered on its "effective" onset time (see above). The shape of the generation-time distribution is the same for all cases.
The average number of children produced by a case depends on its symptomatic status, and is determined by the overall value, the proportion of asymptomatic carriers , and the relative infectiousness R 0 p asym of asymptomatic carriers (expressed as a fraction of ). Given a reproduction number for x asym R 0 asymptomatics of , the reproduction number of symptomatic cases that produces the R asym = R 0 · x asym desired overall is given by .

Structure of the model -Infection control
Once symptoms develop, a case is identified by public health authorities with probability , with the p isol delay from onset to identification drawn from a delay distribution . Identified cases are instructed to isolate, and each case complies with that order with probability . Cases that comply with isolation p comply generate no further child cases after their time of identification. Asymptomatic cases cannot be identified from symptoms, but may be identified via contact tracing from other cases (see below); once identified, they are instructed to isolate as above. Tracing can also cause symptomatic cases to be isolated earlier than they would be from symptoms alone.

16
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020. ; https://doi.org/10.1101/2020.05.06.20093369 doi: medRxiv preprint An identified case is tested , which takes time drawn from a test time distribution and returns a positive result with probability equal to the sensitivity of the test (since the model does not consider uninfected individuals, the specificity of the test is also not considered). For asymptomatic cases, or symptomatic cases identified prior to symptom onset, a positive test result is required to initiate contact tracing; symptomatic cases that have already developed symptoms can either be traced immediately upon identification, or require a positive test result prior to tracing, depending on model settings.
Whether before or after a test result is obtained, the contacts of an identified case can also be traced .
Tracing can only proceed outward from a case if they share their contact history, either via a contact-tracing app or with a manual contact tracer (see below). Tracing can identify the children of the traced case (forward tracing), and may also be able to identify its parent (reverse/backward tracing), depending on model settings. The speed and success probability of tracing depend upon whether tracing is conducted digitally or manually, which in turn depends on several factors: • If the contact between the trace originator and the tracee occurred environmentally (determined with probability ), tracing cannot take place. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020. • If neither digital nor manual tracing succeeds, then the trace fails and the tracee is not traced.
Cases that are successfully traced are identified at a time equal to the trace initiation time of the trace originator plus a delay time drawn from the appropriate trace delay distribution (which will differ between digital and manual tracing). Cases identified through tracing can then be isolated, tested, and traced as described above. If a case is isolated through tracing earlier than they would have been otherwise, child cases whose exposure time would be later than their parent's new isolation time are eliminated, as are their descendents.

Run initiation and termination
A simulation of an outbreak under the branching-process model is initialised with a given number of index cases (by default 20, in order to reduce the probability of stochastic elimination) and proceeds generation by generation until either no further child cases are generated (extinction) or the run exceeds one of: In practice, virtually all runs either went extinct or reached the cumulative case limit; across all scenarios tested for all datasets used in Figures 2-4, the overall percentage of runs that terminated as a result of exceeding the time limit was less than 0.02%, and the highest percentage observed for any single scenario was 1.3%. The cumulative case limit, meanwhile, was selected to minimise the chance of a run that would otherwise go extinct being terminated prematurely while preserving computational tractability; in test runs with a cumulative case limit of 100,000 cases, fewer than 2% of extinct runs in any scenario had a cumulative case count of over 10,000.
A terminated run was deemed "controlled" if it reached extinction, and uncontrolled otherwise. The control rate for a scenario was computed as the proportion of runs for that scenario that were controlled. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.
is the total number of runs for that scenario and is the number of controlled runs. Effective reproduction k numbers were computed as the average number of child cases produced across all cases in a run, averaged across all runs in the scenario. For main figures, 1000 runs were performed per scenario; for figures, either 500 or 1000 runs were performed, as specified in the figure captions.

19
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.  is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020. ;  (Table S1) when contacts are traced for varying periods prior to symptom onset (for symptomatic cases) or case identification (for presymptomatic and asymptomatic cases). Panel headers indicate the percentage of non-environmental contacts traced. Error bars in (a) represent 95% credible intervals across 1000 runs under a uniform beta prior; points in (b) represent average values over the same.

21
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.  (Table S1) when contacts are traced up to 2, 7, or 14 days prior to symptom onset (for symptomatic cases) or case identification (for presymptomatic and asymptomatic cases). Error bars in (a) represent 95% credible intervals across 500 runs under a uniform beta prior; points in (b) represent average values over the same.

22
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020. ; https://doi.org/10.1101/2020.05.06.20093369 doi: medRxiv preprint Figure S3: Effect of network fragmentation on performance of forward-only tracing.

Neighbour-averaged contour plot of effective reproduction number achieved under (a) digital-only and (b)
hybrid forward-only tracing, over 1000 runs per scenario, for different levels of smartphone coverage and data-sharing, assuming median disease parameters (Table S1) and a 90% probability of trace success.

23
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.  (Table S1) when contacts are manually traced for varying periods prior to symptom onset (for symptomatic cases) or case identification (for presymptomatic and asymptomatic cases). Data for digital contact tracing is assumed to be retained for 14 days after contact. Panel headers indicate the percentage of non-environmental contacts traced. Error bars in (a) represent 95% credible intervals across 1000 runs under a uniform beta prior; points in (b) represent average values over the same.

24
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020. 25 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.  (Table S1) and a 90% probability of trace success.

26
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.  (Table S1) and a 90% probability of trace success.

27
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020. 28 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020. ; https://doi.org/10.1101/2020.05.06.20093369 doi: medRxiv preprint Figure S9: Effect of R 0 and disease parameters on tracing performance (80% trace rate). As Figure   3, but assuming 80% of non-environmental contacts are traced. Error bars in (a,c,e) represent 95% credible intervals across 1000 runs under a uniform beta prior; points in (b) represent average values over the same.

29
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.

30
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

31
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.

32
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.

33
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.  (Table S1), 90% of non-environmental contacts traced and a 7-day manual trace window. Environmental transmission is assumed to be untraceable by either manual or digital contact tracing. Error bars in (a) represent 95% credible intervals across 500 runs under a uniform beta prior; points in (b) represent average values over the same.

47
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.  (Table S1), 90% of non-environmental contacts traced and a 7-day manual trace window. Error bars in (a) represent 95% credible intervals across 500 runs under a uniform beta prior; points in (b) represent average values over the same.

48
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.  (Table S1), 90% of non-environmental contacts traced and a 7-day manual trace window. Error bars in (a) represent 95% credible intervals across 500 runs under a uniform beta prior; points in (b) represent average values over the same.

49
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020.  (Table S1), 90% of non-environmental contacts traced and a 7-day manual trace window. Error bars in (a) represent 95% credible intervals across 500 runs under a uniform beta prior; points in (b) represent average values over the same.

50
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted July 14, 2020. average effective reproduction numbers achieved as a function of the probability of identifying symptomatic cases (based on symptoms alone), assuming otherwise median disease parameters (Table   S1), 90% probability of trace success, and a 7-day manual trace window. Error bars in (a) represent 95% credible intervals across 500 runs under a uniform beta prior; points in (b) represent average values over the same. Note that, since 45% of cases are asymptomatic (and thus never identified from symptoms), overall ascertainment when of symptomatic cases are identified is roughly . % x .55x% 0 51 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 14, 2020.  (Table S1), given 90% of non-environmental contacts traced, high uptake of the digital system, and immediate tracing of symptomatic cases.

52
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 14, 2020. ; https://doi.org/10.1101/2020.05.06.20093369 doi: medRxiv preprint Figure S33. Tracing strategies for controlling COVID-19 ( R 0 = 2.0). As Fig. 4, but assuming an R 0 of 2.0. Blue ‡ symbols indicate current practice in most regions. Low and high uptake correspond to 53% and 80% of cases, respectively, having chirp-enabled smartphones. Error bars in (a) represent 95% credible intervals across 1000 runs under a uniform beta prior. Without tracing, forward and bidirectional are equivalent.

53
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 14, 2020. ; https://doi.org/10.1101/2020.05.06.20093369 doi: medRxiv preprint Figure S34. Tracing strategies for controlling COVID-19 ( R 0 = 3.0). As Fig. 4, but assuming an R 0 of 3.0. Blue ‡ symbols indicate current practice in most regions. Low and high uptake correspond to 53% and 80% of cases, respectively, having chirp-enabled smartphones. Error bars in (a) represent 95% credible intervals across 1000 runs under a uniform beta prior. Without tracing, forward and bidirectional are equivalent.

54
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 14, 2020. ; https://doi.org/10.1101/2020.05.06.20093369 doi: medRxiv preprint Figure S35. Tracing strategies for controlling COVID-19 (80% contacts traced). As Fig. 4, but assuming only 80% of non-environmental contacts are traced. Blue ‡ symbols indicate current practice in most regions. Low and high uptake correspond to 53% and 80% of cases, respectively, having chirp-enabled smartphones. Error bars in (a) represent 95% credible intervals across 1000 runs under a uniform beta prior. Without tracing, forward and bidirectional are equivalent.

55
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 14, 2020. ; https://doi.org/10.1101/2020.05.06.20093369 doi: medRxiv preprint Figure S36. Tracing strategies for controlling COVID-19 (pre-emptive testing). As Fig. 4, but assuming that symptomatic cases require a positive test before their contacts are traced. Blue ‡ symbols indicate current practice in most regions. Low and high uptake correspond to 53% and 80% of cases, respectively, having chirp-enabled smartphones. Error bars in (a) represent 95% credible intervals across 1000 runs under a uniform beta prior. Without tracing, forward and bidirectional are equivalent.

56
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 14, 2020. ; https://doi.org/10.1101/2020.05.06.20093369 doi: medRxiv preprint